WallStreetZenWallStreetZen

NYSE: MRK
Merck & Co Inc Stock Ownership - Who owns Merck & Co?

Open Broker Account

Insider buying vs selling

Have Merck & Co Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Steven MizellEVP Chief HR Officer2022-11-1015,000$101.42
$1.52MSell
Robert M. DavisCEO President2022-11-09100$103.59
$10.36kSell
Robert M. DavisCEO President2022-11-0987,595$101.94
$8.93MSell
Johannes Jacobus OosthuizenPresident U.S. Market2022-11-091,795$103.21
$185.26kSell
Robert M. DavisCEO President2022-11-0979,918$102.98
$8.23MSell
Steven MizellEVP Chief HR Officer2022-11-0820,000$101.00
$2.02MSell
Kenneth C. FrazierExecutive Chair2022-11-0784,721$100.07
$8.48MSell
Johannes Jacobus OosthuizenPresident U.S. Market2022-11-0745,561$99.47
$4.53MSell
Kenneth C. FrazierExecutive Chair2022-11-0724,914$98.45
$2.45MSell
Kenneth C. FrazierExecutive Chair2022-11-07126,134$99.43
$12.54MSell

1 of 10

MRK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRK insiders and whales buy or sell their stock.

MRK Shareholders

What type of owners hold Merck & Co Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.84%224,134,448$24.66BInstitution
Blackrock Inc8.46%214,507,760$23.60BInstitution
State Street Corp4.63%117,311,329$12.91BInstitution
Geode Capital Management LLC1.90%48,100,919$5.29BInstitution
Wellington Management Group LLP1.58%40,157,172$4.42BInstitution
Bank Of America Corp1.58%40,007,529$4.40BInstitution
Morgan Stanley1.49%37,849,265$4.16BInstitution
Bank Of New York Mellon Corp1.22%31,049,211$3.42BInstitution
Charles Schwab Investment Management Inc1.22%30,950,448$3.41BInstitution
Northern Trust Corp1.18%29,890,121$3.29BInstitution

1 of 3

MRK vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRK72.97%0.18%Net SellingNet Selling
PFE67.68%0.26%Net BuyingNet Buying
ABBV67.75%0.14%Net Selling
AZN32.88%0.00%
LLY82.16%11.58%Net SellingNet Selling

Merck & Co Stock Ownership FAQ

Who owns Merck & Co?

Merck & Co (NYSE: MRK) is owned by 72.97% institutional shareholders, 0.18% Merck & Co insiders, and 26.84% retail investors. Vanguard Group Inc is the largest individual Merck & Co shareholder, owning 224.13M shares representing 8.84% of the company. Vanguard Group Inc's Merck & Co shares are currently valued at $24.66B.

If you're new to stock investing, here's how to buy Merck & Co stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.